小管间质性肾炎和葡萄膜炎(TINU)综合征:一个病例系列。

IF 2.3 Q1 OPHTHALMOLOGY
Richard Farnan, John Stokes, Rob Casey, Aisling McGlacken Byrne, Sean Leavey
{"title":"小管间质性肾炎和葡萄膜炎(TINU)综合征:一个病例系列。","authors":"Richard Farnan, John Stokes, Rob Casey, Aisling McGlacken Byrne, Sean Leavey","doi":"10.1186/s12348-025-00500-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Tubulointerstitial nephritis and uveitis (TINU) syndrome, characterised by the co-occurrence of tubulointerstitial nephritis and uveitis in the absence of other systemic diseases, presents a diagnostic challenge due to its non-specific symptoms. This case series aims to shed light on TINU syndrome's clinical features, underlying causes, and management strategies. The prevalence of TINU syndrome is relatively low with estimates of 3.5 cases/ million people with an incidence of 0.2 cases/ million/ year and it often goes underdiagnosed. The ratio of males to females reported was 4:1. Histological confirmation through renal biopsy is crucial, while systemic conditions such as systemic lupus erythematosus, tuberculosis, sarcoidosis, and Sjogren's disease should be excluded. In most cases, TINU appears to be an idiopathic immune-mediated process, but it may be precipitated by drugs or infections. Antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with some cases of TINU syndrome. Genetic markers, particularly HLA subtypes, have shown a strong association with TINU syndrome. Uveitis which is characterised by intraocular inflammation is a common feature of TINU syndrome. Anterior uveitis, the most prevalent form, presents with symptoms such as red eye, eye pain, photophobia, and keratic precipitates which are subdivided into granulomatous and non-granulomatous. Corticosteroids represent the primary treatment for ocular inflammation, while immunosuppressant medications may be employed for treatment of nephritis.</p><p><strong>Observations: </strong>Through the analysis of five TINU syndrome cases, this case series provides insights into the clinical presentations, laboratory findings, and biopsy results of patients with TINU syndrome. The cases include individuals with associated systemic conditions such as asthma, psoriasis and hyperthyroidism.</p><p><strong>Conclusion and importance: </strong>In conclusion, TINU syndrome is a rare condition characterised by the simultaneous occurrence of tubulointerstitial nephritis and uveitis. Increased awareness among healthcare professionals is necessary for early recognition and appropriate management of this syndrome. Further research is needed to elucidate the pathogenesis, optimise diagnostic criteria, and explore more targeted therapeutic approaches for TINU syndrome.</p>","PeriodicalId":16600,"journal":{"name":"Journal of Ophthalmic Inflammation and Infection","volume":"15 1","pages":"55"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12274152/pdf/","citationCount":"0","resultStr":"{\"title\":\"Tubulointerstitial nephritis and uveitis (TINU) syndrome: a case series.\",\"authors\":\"Richard Farnan, John Stokes, Rob Casey, Aisling McGlacken Byrne, Sean Leavey\",\"doi\":\"10.1186/s12348-025-00500-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Tubulointerstitial nephritis and uveitis (TINU) syndrome, characterised by the co-occurrence of tubulointerstitial nephritis and uveitis in the absence of other systemic diseases, presents a diagnostic challenge due to its non-specific symptoms. This case series aims to shed light on TINU syndrome's clinical features, underlying causes, and management strategies. The prevalence of TINU syndrome is relatively low with estimates of 3.5 cases/ million people with an incidence of 0.2 cases/ million/ year and it often goes underdiagnosed. The ratio of males to females reported was 4:1. Histological confirmation through renal biopsy is crucial, while systemic conditions such as systemic lupus erythematosus, tuberculosis, sarcoidosis, and Sjogren's disease should be excluded. In most cases, TINU appears to be an idiopathic immune-mediated process, but it may be precipitated by drugs or infections. Antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with some cases of TINU syndrome. Genetic markers, particularly HLA subtypes, have shown a strong association with TINU syndrome. Uveitis which is characterised by intraocular inflammation is a common feature of TINU syndrome. Anterior uveitis, the most prevalent form, presents with symptoms such as red eye, eye pain, photophobia, and keratic precipitates which are subdivided into granulomatous and non-granulomatous. Corticosteroids represent the primary treatment for ocular inflammation, while immunosuppressant medications may be employed for treatment of nephritis.</p><p><strong>Observations: </strong>Through the analysis of five TINU syndrome cases, this case series provides insights into the clinical presentations, laboratory findings, and biopsy results of patients with TINU syndrome. The cases include individuals with associated systemic conditions such as asthma, psoriasis and hyperthyroidism.</p><p><strong>Conclusion and importance: </strong>In conclusion, TINU syndrome is a rare condition characterised by the simultaneous occurrence of tubulointerstitial nephritis and uveitis. Increased awareness among healthcare professionals is necessary for early recognition and appropriate management of this syndrome. Further research is needed to elucidate the pathogenesis, optimise diagnostic criteria, and explore more targeted therapeutic approaches for TINU syndrome.</p>\",\"PeriodicalId\":16600,\"journal\":{\"name\":\"Journal of Ophthalmic Inflammation and Infection\",\"volume\":\"15 1\",\"pages\":\"55\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12274152/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Ophthalmic Inflammation and Infection\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s12348-025-00500-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmic Inflammation and Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12348-025-00500-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:小管间质性肾炎和葡萄膜炎(TINU)综合征,在没有其他全身性疾病的情况下,以小管间质性肾炎和葡萄膜炎共存为特征,由于其非特异性症状,给诊断带来了挑战。本病例系列旨在阐明TINU综合征的临床特征,潜在原因和管理策略。TINU综合征的患病率相对较低,估计为3.5例/百万人,发病率为0.2例/百万人/年,并且经常未得到诊断。男女比例为4:1。肾活检的组织学证实是至关重要的,而系统性疾病如系统性红斑狼疮、肺结核、结节病和干燥病应排除在外。在大多数情况下,TINU似乎是一个特发性免疫介导的过程,但它可能是由药物或感染沉淀。抗生素和非甾体抗炎药(NSAIDs)与一些TINU综合征病例有关。遗传标记,特别是HLA亚型,已显示与TINU综合征密切相关。以眼内炎症为特征的葡萄膜炎是TINU综合征的共同特征。葡萄膜前炎是最常见的一种,表现为红眼、眼痛、畏光和角状沉淀,可分为肉芽肿性和非肉芽肿性。皮质类固醇是眼部炎症的主要治疗方法,而免疫抑制药物可用于治疗肾炎。观察:通过对5例TINU综合征病例的分析,本病例系列对TINU综合征患者的临床表现、实验室表现和活检结果有了深入的了解。这些病例包括患有哮喘、牛皮癣和甲状腺功能亢进等相关全身性疾病的个体。结论及重要性:总之,TINU综合征是一种罕见的以小管间质性肾炎和葡萄膜炎同时发生为特征的疾病。提高卫生保健专业人员的认识对于早期识别和适当管理这种综合征是必要的。需要进一步的研究来阐明发病机制,优化诊断标准,探索更有针对性的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Tubulointerstitial nephritis and uveitis (TINU) syndrome: a case series.

Tubulointerstitial nephritis and uveitis (TINU) syndrome: a case series.

Purpose: Tubulointerstitial nephritis and uveitis (TINU) syndrome, characterised by the co-occurrence of tubulointerstitial nephritis and uveitis in the absence of other systemic diseases, presents a diagnostic challenge due to its non-specific symptoms. This case series aims to shed light on TINU syndrome's clinical features, underlying causes, and management strategies. The prevalence of TINU syndrome is relatively low with estimates of 3.5 cases/ million people with an incidence of 0.2 cases/ million/ year and it often goes underdiagnosed. The ratio of males to females reported was 4:1. Histological confirmation through renal biopsy is crucial, while systemic conditions such as systemic lupus erythematosus, tuberculosis, sarcoidosis, and Sjogren's disease should be excluded. In most cases, TINU appears to be an idiopathic immune-mediated process, but it may be precipitated by drugs or infections. Antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with some cases of TINU syndrome. Genetic markers, particularly HLA subtypes, have shown a strong association with TINU syndrome. Uveitis which is characterised by intraocular inflammation is a common feature of TINU syndrome. Anterior uveitis, the most prevalent form, presents with symptoms such as red eye, eye pain, photophobia, and keratic precipitates which are subdivided into granulomatous and non-granulomatous. Corticosteroids represent the primary treatment for ocular inflammation, while immunosuppressant medications may be employed for treatment of nephritis.

Observations: Through the analysis of five TINU syndrome cases, this case series provides insights into the clinical presentations, laboratory findings, and biopsy results of patients with TINU syndrome. The cases include individuals with associated systemic conditions such as asthma, psoriasis and hyperthyroidism.

Conclusion and importance: In conclusion, TINU syndrome is a rare condition characterised by the simultaneous occurrence of tubulointerstitial nephritis and uveitis. Increased awareness among healthcare professionals is necessary for early recognition and appropriate management of this syndrome. Further research is needed to elucidate the pathogenesis, optimise diagnostic criteria, and explore more targeted therapeutic approaches for TINU syndrome.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.80
自引率
3.40%
发文量
39
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信